Le Grand Associates Inc | |
214 W Main St, Ste 102, Moorestown, New Jersey 08057 | |
(856) 273-8565 |
Name | Le Grand Associates Inc |
---|---|
Organization Name | Le Grand Associates Inc |
Location | 214 W Main St, Ste 102, Moorestown, New Jersey 08057 |
Type | DME Supplier - Customized Equipment |
Phone | (856) 273-8565 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.
In a Friday appearance before the House Ways and Means Committee, HHS Secretary Kathleen Sebelius offered assurances about the readiness of 33 federally run health insurance marketplaces and answered questions about health care "navigators."
The Biden administration said Friday that it has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Donald Trump as a key strategy to control costs.
› Verified 2 days ago
NPI Number | 1457418931 |
Organization Name | LE GRAND ASSOCIATES INC |
Type | DME Supplier - Customized Equipment |
Address | 214 W Main St, York House East Suite 102, Moorestown, NJ 08057 |
Phone Number | 856-273-8565 |
News Archive
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.
In a Friday appearance before the House Ways and Means Committee, HHS Secretary Kathleen Sebelius offered assurances about the readiness of 33 federally run health insurance marketplaces and answered questions about health care "navigators."
The Biden administration said Friday that it has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Donald Trump as a key strategy to control costs.
› Verified 2 days ago
News Archive
Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.
Researchers at the University of Puerto Rico, School of Medicine have found a way to pharmacologically induce a memory of safety in the brain of rats. As reported in the June, 4 2010 issue of Science, administering brain-derived neurotrophic factor into the prefrontal cortex prevented rats from expressing fear to a tone that had been previously paired with a shock.
In a Friday appearance before the House Ways and Means Committee, HHS Secretary Kathleen Sebelius offered assurances about the readiness of 33 federally run health insurance marketplaces and answered questions about health care "navigators."
The Biden administration said Friday that it has no timeline on whether it will allow states to import drugs from Canada, an effort that was approved under President Donald Trump as a key strategy to control costs.
› Verified 2 days ago
Carl's Shoes Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 27 W Main St, Moorestown, New Jersey 08057 Phone: (856) 235-6223 | |
Le Grand Associates Inc Type: DME Supplier - Customized Equipment Location: 214 W Main St, Moorestown, New Jersey 08057 Phone: (856) 273-8565 | |
Lenscrafters #01045 Type: Eyewear Supplier (Equipment, not the service) Location: 400 W Route 38, Moorestown, New Jersey 08057 Phone: (856) 787-0102 | |
Cvs Pharmacy #02409 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 219 W Main St, Moorestown, New Jersey 08057 Phone: (856) 914-2021 | |
South Jersey Eye Physicians Type: Durable Medical Equipment & Medical Supplies Supplier Location: 509 S Lenola Rd, Moorestown, New Jersey 08057 Phone: (856) 234-0258 |